baber/WOPTO huggingface dataset:
Patent NZ-515802-A (NZ)
Title: Method and apparatus for making internally-reinforced bag assembly
Inventor: LOTTO RONALD L
IPC: B31B39/00
Filed: 2000-05-23
Abstract: A process for making an internally-reinforced bag assembly includes formation of an outer bag body with a plurality of longitudinally oriented, laterally spaced pleats or tucks therein. An inner reinforcement layer is applied to the outer bag body after formation of the pleats, whereby the inner layer spans and overlaps each of the pleats. An apparatus embodying the present invention effects bag formation in this fashion. Advancement through the forming apparatus effects formation of the outer web into a gusseted tube, and formation of a square bottom seal. The completed bag assembly includes the inner reinforcement layer, which is dimensioned to define a circumference which is less than a circumference defined by the bag body. The resultant bag assembly resists bulging and deformation under the influence of particulate, granular, or other flowable products packaged therein.
Patent NZ-516338-A (NZ)
Title: 2-(4-Pyridyl)-5-sulphonyl-benzofuran derivatives useful as metalloprotease inhibitors
Inventor: DE NANTEUIL GUILLAUME
IPC: A61P35/00
Filed: 2001-12-21
Abstract: A 2-(4-pyridinyl)-benzofuran derivative or an isomer, N-oxide or salt thereof useful as a metalloprotease inhibitor has the formula (I) wherein: R1 is H, halo, alkyl or alkoxy; X is oxygen, sulphur or NR; R is H or alkyl; A is a group of formula (2); Ra is H, alkyl or alkoxy; Rb and Rc is independently H or alkyl and n is 0 to 2.
Patent NZ-519941-A (NZ)
Title: Emulsifiable concentrate compositions with silicone antifoams
Inventor: SUN JINXIA
IPC: C09K23/42
Filed: 2001-01-05
Abstract: An emulsifiable concentrate comprises an organic solvent soluble pesticide, an emulsifier and a silicon antifoam. The silicone antifoam has the structure: [R2(R1)2SiO1/2]e[SiO4/2]f[SiO3/2R1]g[SiO2/2(R1)2]x[SiO2/2R1Z]y wherein: e= 2*f + g + 2; f = 0 to 2, g = 0 to 2, x = 30-150, y = 0-30, where when y > O, x/y= 4 to 18, and x +y > = 30; and when y = 0, then x/e is 20/1 to 10/1; R1 = alkyl of 1-18 carbon; R2 = R1 or Z with the proviso that when y = 0, R2 = Z; Z = R4OBnG; R4 is a divalent bridging group of 2-4 carbons, B is an alkylene oxide group containing 2-4 carbon (EO/PO/BO), wherein less than ten mole percent of the alkylene oxide functionalities are ethylene oxide; n =8-30, and G= H, hydrocarbon radical of 1-18 carbons, or acetyl.
Patent NZ-520280-A (NZ)
Title: Pseudopolymorph of (-)-CIS-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-one
Inventor: BAFUS GARY L
IPC: C07D405/04
Filed: 2001-01-08
Abstract: Pseudopolymorph Form I having an x-ray powder diffraction pattern expressed in terms of "D" spacing of - 12.708, 4.323, 5.594, 5.349, 3.590 angstrom. The use of the above compound for treating cancer, and inhibiting protein kinases. A process for their production is also disclosed.
Patent NZ-520425-A (NZ)
Title: Controller to switch a user's connection from subscriber line to high speed line on user' request
Inventor: AOKI YASUTAKA
IPC: H04L12/12
Filed: 2002-07-29
Abstract: A line connection controller comprises: a line switching device (12) which switches a subscriber (10) to an Asymmetric Digital Subscriber Line ("ADSL") through a subscriber line, and a switching equipment (11) which controls the line switching device (12) in accordance with a request from a subscriber (10), wherein the switching equipment (11) comprises line switching instruction means for instructing the line switching device (12) to switch the line on the basis of a line connection/disconnection request from the subscriber (10) , and charging means for executing charging corresponding to a high-speed line (13) use time from connection to disconnection between the subscriber line and the ADSL, and the line switching device (12) comprises line switching means for switching the subscriber line to the ADSL thorough the subscriber line in accordance with an instruction from the line switching instruction means.
Patent NZ-523560-A (NZ)
Title: Microarray method of genotyping multiple samples at multiple loci
Inventor: SCHENA MARK A
IPC: C12Q1/68
Filed: 2001-07-03
Abstract: A method of simultaneously genotyping multiple samples in a single round of hybridization, comprising: 1) incubating a microarray of polynucleotide samples from multiple individuals with a single solution of a probe mixture of oligonucleotides of known sequence; and 2) detecting at the distinct locations on the microarray after a single round of hybridization, stable hybrids formed during the incubation, wherein a hybridization signal indicating the formation of a hybrid or lack of formation of a hybrid genotypes the individuals. The microarray contains a plurality of samples containing genotypes of interest with each sample in a distinct location. Each sample has amplified polynucleotides with a defined segment containing a marker selected from a marker for a gene and markers for allelic variants of the gene. The oligonucleotides in the probe mixture are of known sequence and length and have sequences specifically complementary to polynucleotide sequences within the defined segments for each sample for which a genotype is to be determined, wherein the oligonucleotides complementary to the polynucleotides are selected from the group consisting of oligonucleotides with sequences complementary to a segment containing the marker for (1) a gene, (2) one or more allelic variants of the gene, and (3) a gene and one or more allelic variants of the gene, and the incubating forms hybrids of polynucleotides of the microarray and complementary oligonucleotides and allows discrimination at single nucleotide resolution. Preferably the allele of the gene is associated with a disease and the gene is selected from beta-globin, cystic fibrosis transmembrane conductance regulator (CFTR) and Galactose-1-Phosphate Uridyltransferase (Gal-1PU).
Patent NZ-524572-A (NZ)
Title: Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions
Inventor: MURAKAMI HIDEKI
IPC: A61K45/00
Filed: 2001-09-06
Abstract: A preparation for oral administration containing as an active ingredient a medicinal substance having cGMP-specific phosphodiesterase inhibitory activity and showing decrease of solubility in the neutral and alkaline regions also comprises and acidic substance. Preferably the medicinal substance is a compound of formula (I) wherein A is a optionally substituted nitrogen-containing heterocyclic group; R1 is an optionally substituted lower alkyl group, a group of formula Q-R3, a group of the formula: -NH-R4, wherein R3 is an optionally substituted nitrogen-containing heterocyclic group, Q is a lower alkylene group or a single bond and R4 is an optionally substituted cycloalkyl group; R2 is an optionally substituted aryl group; one of Y and Z is =CH- and the other is =N-. Preferably the acidic substance is fumaric acid, tartaric acid, succinic acid, malic acid, ascorbic acid or aspartic acid and preparation is a tablet.
Patent NZ-525323-A (NZ)
Title: Color separation method and printed product of the method
Inventor: LEE DAVID L
IPC: H04N1/58
Filed: 2003-04-15
Abstract: A method of making colour separations for printing which comprises preparing n digital colour separations of an original colour image, where n is 2 or greater, one separation being black or a surrogate colour for black; processing the separations, other than the black or surrogate separation for black through a low pass filter to degrade image detail and recombining all of the separations for printing, whereby the visual tolerance of any colour misregistration in the ultimate printed image is increased.
Patent NZ-527522-A (NZ)
Title: Use of a chemopreventative agent in a method for chemoprevention of prostate cancer
Inventor: STEINER MITCHELL S
IPC: A61K31/135
Filed: 1999-05-07
Abstract: The use of a compound of formula (1) wherein R1 and R2, which can be the same or different, are H or OH; R3 is OCH2CH2NR4R5, wherein R4 and R5, which can be the same or different, are H or an alkyl group of 1 to about 4 carbon atoms, or a pharmaceutically acceptable salt, ester, N-oxide, or mixture thereof, in the manufacture of a pharmaceutical preparation for use in preventing prostate carcinogenesis in a subject or preventing recurrence of, suppressing or inhibiting prostate carcinogenesis, or increasing survival rate of a subject having prostate cancer is disclosed. The subject may have benign prostatic hyperplasia, prostatic intraepithelial neoplasia (PIN), or an abnormally high level of circulating prostate specific antibody (PSA). (62) Divided out of 502719
Patent NZ-528384-A (NZ)
Title: Abrasion-resistant agglomerate mineral substance granule, powder comprising such granules and production method therefor
Inventor: CRIADO CLAUDE
IPC: C01D7/38
Filed: 2002-02-22
Abstract: A granule comprising an agglomerate of particles of a mineral substance, characterized in that the agglomerate is coated with a monolithic outer layer. Also disclosed is a method for producing a powder comprising the granule, involving an agglomeration stage and a coating stage. The plant comprises a roll compactor (2), a crusher (4), a screen unit (6), a saturation tank (8), a heat exchanger (10), a fluidized-bed crystallizer (12) and a dryer (14).
Patent NZ-531034-A (NZ)
Title: Pull-on leader
Inventor: JOSEF MICHAEL J
IPC: D21F7/10
Filed: 2003-06-04
Abstract: Disclosed is a fabric loading leader for installing a papermaker's fabric having a leading edge across its width in the cross-machine direction, the leader comprising a center portion having a width, a rear portion coupled to the center portion, a first ravel area positioned between the center portion and the rear portion so as to allow a rope or cable to be positioned about the rear portion so as to effect a pulling thereon, and means for attaching the leader to the leading edge of the fabric.
Patent NZ-531558-A (NZ)
Title: Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
Inventor: BONIFACIO FAUSTO
IPC: A61K31/4422
Filed: 2002-08-05
Abstract: Disclosed are crude lercanidipine hydrochloride solid Form (A), having a melting point of about 150-152°C (DSC peak) and comprising about 3-4% (w/w) ethyl acetate, crude lercanidipine hydrochloride solid Form (B), having a melting point of about 131-135°C (DSC peak) and comprising about 0.3-0.7% (wlw) ethyl acetate, and isolated lercanidipine hydrochloride Form (II) and methods of producing them. Further disclosed is an antihypertensive pharmaceutical composition comprising crystalline lercanidipine hydrochloride and optionally other forms of lercanidipine, wherein the crystalline lercanidipine hydrochloride is a combnation of crystalline Form (II) with crystalline Form (I).
Patent NZ-535197-A (NZ)
Title: Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
Inventor: DIETRICH RANGO
IPC: A61K45/00
Filed: 2003-02-19
Abstract: An oral dosage form (table or pellet) of a PDE 4 inhibitor with polyvinylpyrrolidone as a binder and one or more other pharmaceutical excipients wherein the PDE 4 inhibitor is a compound of formula I.
Patent NZ-536467-A (NZ)
Title: Vitamin-targeted imaging agents
Inventor: LEAMON CHRISTOPHER PAUL
IPC: A61K47/48
Filed: 2003-05-06
Abstract: Disclosed are compounds of formula (I), wherein: V is a vitamin that is a substrate for receptor-mediated transmembrane transport in vivo, or a vitamin receptor binding derivative or analog thereof, L is a divalent linker, R is a side chain of an amino acid of formula H2NCHRCOOH, M is cation of a radionuclide, n is 1 or 0, and k is 1 or 0. The compounds are used for imaging a population of cells, wherein the cells are characterised by a vitamin receptor on the surface of the cells, by administering the compounds and monitoring the resultant biodistribution.
Patent NZ-538801-A (NZ)
Title: Process for manufacturing extruded mozzarella-type cheese products using steam combined with extrusion processes
Inventor: CORTES-MARTINEZ EDUARDO
Filed: 2005-03-14
Abstract: A process for manufacturing a Mozzarella-type string cheese product is described comprising the steps of (a) providing cheese curd, (b) heating, kneading, and stretching the cheese curd together with any desirable ingredients in a direct steam injection mixer/cooker using direct steam injection into the cheese curd with sufficient mixing to maintain the temperature of the cheese curd at less than about 7000 to obtain a cheese product, (c) extruding the cheese product, and (d) cooling the extruded cheese product to obtain the Mozzarella-type string cheese product, wherein the use of steam injection during heating, kneading, and stretching of the cheese curd leads to a cheese mass which, despite its extrusion, is no longer fibrous or rubbery.
Patent NZ-543341-A (NZ)
Title: Breathable packaging film having enhanced thermoformability
Inventor: LISCHEFSKI ANDREW J
Filed: 2005-10-31
Abstract: Disclosed is a thermoformable coextruded packaging film comprising: (a) three polymeric layers; (b) wherein the first polymeric layer is an outmost exterior-film layer and comprises a material selected from the group consisting of cycloaliphatic polyesters, polyethylene terephthalate (PET), polyethylene terephthalate glycol (PETG), polypropylene terephthalate (PPT), polybutylene terephthalate (PBT) and blends thereof; (c) wherein said second polymeric layer comprises greater than 30% by weight of polypropylene or cross-linked polyethylene; (d) wherein said third polymeric layer is an innermost exterior-film layer comprising a heat-sealable polyolefin; (e) wherein said film has an oxygen transmission rate at 73 Degrees Celsius and 0% R>H. of between 2-1000 centimetres cubed/ 100 inches squared/ 24 hours as measured in accordance with ASTM D-3985-02 test method; and wherein said film comprises an unrestrained linear thermal shrinkage at 80 Degrees Celsius of 0-20% in both the machine and transverse direction as measured in accordance with ASTM D-2732-96 test method. This packaging film has special utility in the packaging of food in the form of fresh poultry, meats, fruits and vegetables.
Patent NZ-548224-A (NZ)
Title: Stroller seat attachment for accommodating infant or toddler, being foldable to collapsed configuration
Inventor: MACIEJCZYK WIESLAW
Filed: 2006-06-28
Abstract: A mounting arrangement for mounting a toddler seat to a pram or stroller having a framework is disclosed. The mounting arrangement includes a first support element that is pivotally attached to the framework and a second support element connected to the first support element. Also included is a mounting portion to attach a toddler seat. The second support element in a first deployed configuration is attachable to the framework to configure the mounting arrangement for the seating of a toddler and the second support element is further releasable from the framework to allow the mounting arrangement to fold or collapse to a compact folded configuration.
Patent NZ-548693-A (NZ)
Title: Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
Inventor: ARORA JALAJ
IPC: A61K31/4545
Filed: 2005-02-17
Abstract: Disclosed is a compound of formula (I), wherein P is aryl or heteroaryl, X6 is N, X2 and X7 are each C or N, Q is heteroaryl, and wherein the rest of the substituents are as described in the specification. Also disclosed is the use of the compound to treat mGluR 5 mediated disorders.
Patent NZ-548933-A (NZ)
Title: Oxidation process and use thereof for preparing moxidectin
Inventor: CULLEN THOMAS GERARD
Filed: 2006-08-04
Abstract: A process for the selective oxidation of a 5-O-protected-LL-F28249-alpha compound of formula (II) to the corresponding 23-keto compound of formula (I), wherein R is a protecting group, which process includes reacting said formula (II) compound with a halochromate oxidizing agent selected from the group consisting of: pyridinium fluorochromate; quinolinium fluorochromate; and 3,5-dimethylpyrazolium fluorochromate. Further disclosed is a process for the manufacture of moxidectin wherein this selective oxidation process is incorporated as a key step.
Patent NZ-549683-A (NZ)
Title: A fluid dispensing device
Inventor: BONNEY STANLEY GEORGE
IPC: B67D7/84
Filed: 2005-03-10
Abstract: The present disclosure relates to a fluid dispensing device (1405) for dispensing a fluid product having a dispensing outlet (1411) from which the fluid product is dispensable, a supply of the fluid product, a dispensing member (1430) mounted for movement in a dispensing direction along an axis X-X from a first position to a second position which causes a dose of the fluid product in the supply to be dispensed from the dispensing outlet, and a finger-operable actuator member (1420) mounted for movement in an actuating direction which is generally transverse to the axis. The actuator member has at least one cam surface (1422) and the dispensing member has at least one cam follower surface (1492). The at least one cam surface has a commitment section (1423a), oriented at a first angle to the axis, and an adjacent drive section (1423b), which is oriented at a second angle to the axis which is greater than the first angle.
Patent NZ-550458-A (NZ)
Title: An exercise training apparatus with rotatable and tiltable target components
Inventor: STEVENSON LEON WILLIAM
Filed: 2004-04-29
Abstract: The present invention relates to an exercise training apparatus and more specifically to a martial arts/boxing training apparatus which overcomes the problems associated with existing devices in that it provides the user with the ability to hone in on skills such as speed, power, accuracy and blocking, and also simulate the unpredictable nature of a real-life sparring partner. The apparatus (10) includes a base plate (12) for mounting the apparatus to a surface, a support member (24), and one or more padded balls (48) that are adapted to move about the support member through connecting arms (44), (46) whose height is adjustable. In one form of the invention, the arms are rigid structures which rotate in a horizontal plane about the support member whereby the length of each arm is adjustable. This embodiment is especially useful when a user wishes to hone in on a particular skill which does not require the element of surprise. In a further form of the invention, the support member includes a flexible arm mounted thereto which is not only capable of rotational movement in a single plane, but is also capable of tiltable and pivotable motion relative to the support member which adds a further dimension to the training apparatus. This embodiment is especially useful when the unpredictable nature of a real-life sparring partner is required.
Patent NZ-552650-A (NZ)
Title: Substituted N-acyl-2-aminothiazoles
Inventor: CAI JIANPING
IPC: A61K31/428
Filed: 2005-07-28
Abstract: The disclosure relates to a pharmaceutical composition comprising a substituted N-acyl-2-aminothiazole of the formula (I), or pharmaceutically acceptable salts thereof, wherein R, R1 and X are as defined in the specification. These compounds are useful in the treatment of diabetes, diabetic retinopathy, asthma and diarrhea.
Patent NZ-553855-A (NZ)
Title: Monoclonal antibodies expressed by ATCC PTA-5065 for the treatment of cancer
Inventor: YOUNG DAVID S F
IPC: A61P35/00
Filed: 2005-03-10
Abstract: Disclosed is the method and use of a cancerous disease modifying monoclonal antibody (ATTC accession number PTA-5065) for treating a human tumour in non-human mammals, when used in effective amounts.
Patent NZ-564609-A (NZ)
Title: Processes for the manufacture of rosuvastatin and intermediates
Inventor: BUTTERS MICHAEL
IPC: C07D239/30
Filed: 2006-07-03
Abstract: Disclosed is a process for the manufacture of a compound of formula (V) comprising a) reaction of a compound of formula (II) wherein each R1 is independently selected from (1-6C)alkyl, and R is selected from (1-6C)alkyl, (3-6C)cycloalkyl or aryl(1-6C)alkyl; with a compound of formula (III) in the presence of titanium (IV) catalyst of formula (IV) wherein each R2 is independently selected from (1-6C)alkyl and the binaphthyl moiety is in the S-configuration), an alkali metal halide salt and an amine, in an inert solvent. Also disclosed are a number of 4(4-fluorophenyl)-6-isoproylpyrimidine derivatives.
Patent NZ-564797-A (NZ)
Title: Cavity well system
Inventor: PRATT CHRISTOPHER A
IPC: E21B43/00
Filed: 2006-05-31
Abstract: Methods and systems for accessing a subterranean zone (12), such as a coal seam, are disclosed. The method includes forming a first bore (14) from a land surface (16) and forming a subterranean cavity (18) in the bore; forming an articulated bore (20) extending from the surface to proximate the subterranean zone; and forming a number of horizontal bores (22) from the articulated bore that are drilled through the cavity (18) and extend at least partially into the subterranean zone (12).
Patent NZ-575280-A (NZ)
Title: Capecitabine pediatric tablets
Inventor: BACHYNSKY MARIA OKSANA
IPC: A61K9/00
Filed: 2007-09-26
Abstract: A film coated pharmaceutical composition of capecitabine that comprises microcrystalline cellulose, a directly compressible polyhydric alcohol and a disintegrant selected from crospovidone and a mannitol/sorbitol combination. The crospovidone has a particle size in the range of 90% less than 15 microns to 90% less than 400 microns. The alcohol can be mannitol. The pharmaceutical composition disintegrates in water at 37 degrees Celsius in a USP Disintegration Apparatus in less than 2 minutes and has a hardness of 8-13 strong Cobb-Units.
Patent NZ-580604-A (NZ)
Title: Foldable and/or disposable luggage formed from blank and ply with wheels to engage with apertured panel of blank
Inventor: MEHTA VINAY K
IPC: A45C5/14
Filed: 2008-03-18
Abstract: The present disclosure provides a luggage, which is mainly foldable and/or disposable. In preferable terms, the present invention provides said foldable and/or disposable luggage made of corrugated board having wheels adapted detachably to the luggage, which makes the luggage easy to handle, store and stackable. Said foldable and/or disposable luggage comprises two main panels, namely top main panel and a bottom main panel, and a plurality of side panels of the luggage formed by folding at least one scored die-cut flat blank, an extended panel, and a ply having wheels aligning with the holes of the said panel.
Patent NZ-581899-A (NZ)
Title: An apparatus for delivering breathable gas to a patient comprising a heating element extending through the flow paths and the humidifier chamber
Inventor: KLASEK PAUL JAN
IPC: A61M16/00
Filed: 2008-06-30
Abstract: Disclosed is an apparatus for delivering breathable gas to a patient. The apparatus comprises a flow generator (22), a humidifier chamber (1), a first flow path (10), a second flow path (4) and a heating element (12). The flow generator (22) generates a flow of breathable gas. The humidifier chamber (1) contains a supply of water (13). The first flow path (10) delivers the flow of breathable gas from the flow generator (22) to the humidifier chamber (1). The second flow path (4) delivers the flow of breathable gas from the humidifier chamber (1) to a patient interface (5). The heating element (12) extends through the first flow path (10), the humidifier chamber (1) and into the second flow path (4).
Patent NZ-584420-A (NZ)
Title: Novel oil in water emulsion vaccine formulations comprising polyoxyethylene-polyoxyproplene block copolymer, mineral oil and a non-ionic hydrophilic ethoxylated fatty alcohol
Inventor: PARISOT ALEXIS GUY ANDRE
IPC: A61K39/02
Filed: 2006-04-13
Abstract: Disclosed is an oil-in -water (O/W) emulsion comprising: (1) an aqueous solution containing a vaccine antigen or immunogen capable of inducing an immune response in a host; (2) A non-ionic lipophilic surfactant which is polyoxyethylene-polyoxypropylene block copolymer (POE-POP block copolymer); (3) A mineral oil; and (4) A non-ionic hydrophilic ethoxylated fatty alcohol.